In a randomised controlled trial of four males aged 4–6 years with DMD, high-dose rAAVrh74.MHCK7 micro-dystrophin cassette avoids the need for dose escalation, thereby minimising AAV exposure [32]. Here, DMD is linked to Duchenne muscular dystrophy.